[{"address1": "550 Reserve Street", "address2": "Suite 360", "city": "Southlake", "state": "TX", "zip": "76092", "country": "United States", "phone": "682 237 7781", "website": "https://heartsciences.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mark T. Hilz", "age": 64, "title": "COO, Secretary & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 263611, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.13, "open": 0.13, "dayLow": 0.1201, "dayHigh": 0.13, "regularMarketPreviousClose": 0.13, "regularMarketOpen": 0.13, "regularMarketDayLow": 0.1201, "regularMarketDayHigh": 0.13, "forwardPE": -0.9014286, "volume": 1606959, "regularMarketVolume": 1606959, "averageVolume": 3668095, "averageVolume10days": 2596260, "averageDailyVolume10Day": 2596260, "bid": 0.1256, "ask": 0.1262, "bidSize": 800, "askSize": 1000, "marketCap": 8223394, "fiftyTwoWeekLow": 0.111, "fiftyTwoWeekHigh": 1.49, "priceToSalesTrailing12Months": 1405.7084, "fiftyDayAverage": 0.13778, "twoHundredDayAverage": 0.49602, "currency": "USD", "enterpriseValue": 10168221, "floatShares": 57927295, "sharesOutstanding": 65161600, "sharesShort": 285911, "sharesShortPriorMonth": 2606961, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0045, "heldPercentInsiders": 0.16499001, "heldPercentInstitutions": 0.018919999, "shortRatio": 0.13, "shortPercentOfFloat": 0.0046, "impliedSharesOutstanding": 65161600, "bookValue": -0.147, "lastFiscalYearEnd": 1682812800, "nextFiscalYearEnd": 1714435200, "mostRecentQuarter": 1698710400, "netIncomeToCommon": -6089709, "trailingEps": -0.6, "forwardEps": -0.14, "enterpriseToRevenue": 1738.157, "enterpriseToEbitda": -1.759, "52WeekChange": -0.8984375, "SandP52WeekChange": 0.30279303, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "HSCS", "underlyingSymbol": "HSCS", "shortName": "Heart Test Laboratories, Inc.", "longName": "Heart Test Laboratories, Inc.", "firstTradeDateEpochUtc": 1655386200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "4248ae6b-5bf9-3528-825f-b590f53c4303", "messageBoardId": "finmb_51732680", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.1262, "targetHighPrice": 3.0, "targetLowPrice": 0.9, "targetMeanPrice": 1.95, "targetMedianPrice": 1.95, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 100144, "totalCashPerShare": 0.002, "ebitda": -5779896, "totalDebt": 1998473, "quickRatio": 0.029, "currentRatio": 0.513, "totalRevenue": 5850, "revenuePerShare": 0.001, "returnOnAssets": -1.01703, "freeCashflow": -4000529, "operatingCashflow": -5274180, "grossMargins": 0.61026, "operatingMargins": -402.5495, "financialCurrency": "USD", "trailingPegRatio": null}]